Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,159 | -23,953 | -27,168 | -28,688 | -18,206 |
| Depreciation Amortization | 1,379 | 1,469 | 2,014 | 2,090 | 1,998 |
| Accounts receivable | 2,621 | -1,850 | -2,849 | 815 | -919 |
| Other Working Capital | 2,933 | -2,825 | -358 | 1,395 | -421 |
| Other Operating Activity | 9,426 | 14,819 | 3,684 | 3,774 | 2,879 |
| Operating Cash Flow | $-8,800 | $-12,340 | $-24,677 | $-20,613 | $-14,669 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 111 | -11 | 12,703 | -534 | -9,447 |
| PPE Investments | -931 | -369 | -1,270 | -767 | -1,071 |
| Net Acquisitions | N/A | -11 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,063 | -848 | -857 | -687 | -397 |
| Other Investing Activity | -1,063 | -848 | -857 | -687 | -397 |
| Investing Cash Flow | $-1,883 | $-1,239 | $10,576 | $-1,988 | $-10,915 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -74 | -113 | N/A | N/A | N/A |
| Common Stock Issued | 47,840 | 81 | 18,745 | 8,163 | 43,527 |
| Financing Cash Flow | $47,766 | $-32 | $18,745 | $8,163 | $43,527 |
| Beginning Cash Position | 11,192 | 24,803 | 20,159 | 34,598 | 16,655 |
| End Cash Position | 48,275 | 11,192 | 24,803 | 20,159 | 34,598 |
| Net Cash Flow | $37,083 | $-13,611 | $4,644 | $-14,439 | $17,943 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,800 | -12,340 | -24,677 | -20,613 | -14,669 |
| Capital Expenditure | -931 | -369 | -1,270 | -767 | -1,071 |
| Free Cash Flow | -9,731 | -12,709 | -25,947 | -21,381 | -15,740 |